Related references
Note: Only part of the references are listed.Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms
Heidi I. L. Jacobs et al.
MOLECULAR PSYCHIATRY (2021)
Determining Amyloid-beta Positivity Using F-18-AZD4694 PET Imaging
Joseph Therriault et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
Topographic Distribution of Amyloid-β, Tau, and Atrophy in Patients With Behavioral/Dysexecutive Alzheimer Disease
Joseph Therriault et al.
NEUROLOGY (2021)
Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression
Kenneth Wengler et al.
NEUROPSYCHOPHARMACOLOGY (2021)
A case-control study of the locus coeruleus degeneration in Alzheimer's disease
Ruihua Hou et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2021)
MRI-assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction
Jeremy A. Elman et al.
ALZHEIMERS & DEMENTIA (2021)
In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer's disease pathology and cognitive decline
Heidi I. L. Jacobs et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Mild behavioral impairment is associated with β-amy o not tau or neurodegeneration in cognitively intact elder individuals
Firoza Z. Lussier et al.
ALZHEIMERS & DEMENTIA (2020)
Association of Apolipoprotein E epsilon 4 With Medial Temporal Tau Independent of Amyloid-beta
Joseph Therriault et al.
JAMA NEUROLOGY (2020)
18F-MK-6240 PET for early and late detection of neurofibrillary tangles
Tharick A. Pascoal et al.
BRAIN (2020)
Dynamic behavior of the locus coeruleus during arousal-related memory processing in a multi-modal 7T fMRI paradigm
Heidi Il Jacobs et al.
ELIFE (2020)
Locus coeruleus: a new look at the blue spot
Gina R. Poe et al.
NATURE REVIEWS NEUROSCIENCE (2020)
What's That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease
Michael Kelberman et al.
FRONTIERS IN NEUROSCIENCE (2020)
Unraveling the contributions to the neuromelanin-MRI contrast
Nikos Priovoulos et al.
BRAIN STRUCTURE & FUNCTION (2020)
Magnetic resonance imaging of noradrenergic neurons
Takashi Watanabe et al.
BRAIN STRUCTURE & FUNCTION (2019)
Neuromelanin-sensitive MRI as a noninvasive proxy measure of dopamine function in the human brain
Clifford M. Cassidy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging
Janina Krell-Roesch et al.
TRANSLATIONAL PSYCHIATRY (2019)
Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue
Cinthya Aguero et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)
Early alteration of the locus coeruleus in phenotypic variants of Alzheimer's disease
Pauline Olivieri et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review
Alireza Showraki et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease
Yue Cui et al.
JOURNAL OF ALZHEIMERS DISEASE (2019)
The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease
David Braun et al.
BRAIN RESEARCH (2019)
Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging
Akiko Satoh et al.
BRAIN RESEARCH (2019)
The neurochemistry of agitation in Alzheimer's disease: a systematic review
Kathy Y. Liu et al.
AGEING RESEARCH REVIEWS (2018)
High-resolution in vivo imaging of human locus coeruleus by magnetization transfer MRI at 3T and 7T
Nikos Priovoulos et al.
NEUROIMAGE (2018)
Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
David Weinshenker
TRENDS IN NEUROSCIENCES (2018)
Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment
Sabela C. Mallo et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
In vivo quantification of neurofibrillary tangles with [18F]MK-6240
Tharick A. Pascoal et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease
David Sulzer et al.
NPJ PARKINSONS DISEASE (2018)
Evaluation of the noradrenergic system in Parkinson's disease: an C-11-MeNER PET and neuromelanin MRI study
Michael Sommerauer et al.
BRAIN (2018)
Depressive Symptoms and Tau Accumulation in the Inferior Temporal Lobe and Entorhinal Cortex in Cognitively Normal Older Adults: A Pilot Study
Jennifer R. Gatchel et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
The Mild Behavioral Impairment Checklist (MBI-C): A Rating Scale for Neuropsychiatric Symptoms in Pre- Dementia Populations
Zahinoor Ismail et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability
Mara Mather et al.
NEUROIMAGE (2017)
Functional dichotomy in spinal- vs prefrontal-projecting locus coeruleus modules splits descending noradrenergic analgesia from ascending aversion and anxiety in rats
Stefan Hirschberg et al.
ELIFE (2017)
Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery
Panos Theofilas et al.
ALZHEIMERS & DEMENTIA (2017)
Defining imaging biomarker cut points for brain aging and Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2017)
Optimal Cut-Off Value for Locus Coeruleus-to-Pons Intensity Ratio as Clinical Biomarker for Alzheimer's Disease: A Pilot Study
Milos Dordevic et al.
JOURNAL OF ALZHEIMERS DISEASE REPORTS (2017)
Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?
Debby Van Dam et al.
CURRENT ALZHEIMER RESEARCH (2016)
Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine
Patricia Szot et al.
NEUROPHARMACOLOGY (2016)
Histologic validation of locus coeruleus MRI contrast in post-mortem tissue
Noam I. Keren et al.
NEUROIMAGE (2015)
Noradrenergic dysfunction in Alzheimer's disease
Mary Gannon et al.
FRONTIERS IN NEUROSCIENCE (2015)
Detection of changes in the locus coeruleus in patients with mild cognitive impairment and Alzheimer's disease: High-resolution fast spin-echo T1-weighted imaging
Junko Takahashi et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2015)
Brain Region-Specific Monoaminergic Correlates of Neuropsychiatric Symptoms in Alzheimer's Disease
Yannick Vermeiren et al.
JOURNAL OF ALZHEIMERS DISEASE (2014)
Simultaneous imaging of locus coeruleus and substantia nigra with a quantitative neuromelanin MRI approach
Xiangchuan Chen et al.
MAGNETIC RESONANCE IMAGING (2014)
The coeruleus/subcoeruleus complex in rapid eye movement sleep behaviour disorders in Parkinson's disease
Daniel Garcia-Lorenzo et al.
BRAIN (2013)
Head-to-Head Comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for β-Amyloid Imaging in Aging and Dementia
Christopher C. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Clinical Validation of 18F-AZD4694, an Amyloid-β-Specific PET Radioligand
Zsolt Cselenyi et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Neuropsychiatric symptoms in Alzheimer’s disease
Constantine G. Lyketsos et al.
Alzheimers & Dementia (2011)
Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
Daniel Weintraub et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Visual discrimination among patients with depression and schizophrenia and healthy individuals using semiquantitative color-coded fast spin-echo T1-weighted magnetic resonance imaging
Makoto Sasaki et al.
NEURORADIOLOGY (2010)
Prazosin for the Treatment of Behavioral Symptoms in Patients With Alzheimer Disease With Agitation and Aggression
Lucy Y. Wang et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2009)
Efficacy of Second Generation Antidepressants in Late-Life Depression: A Meta-Analysis of the Evidence
J Craig Nelson et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Functional neuroanatomy of the noradrenergic locus coeruleus: Its roles in the regulation of arousal and autonomic function part II: Physiological and pharmacological manipulations and pathological alterations of locus coeruleus activity in humans
E. R. Samuels et al.
CURRENT NEUROPHARMACOLOGY (2008)
Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease
Sally I. Sharp et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2007)
Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2006)
Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials
LS Schneider et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2006)
Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies
P Szot et al.
JOURNAL OF NEUROSCIENCE (2006)
Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease
GT Grossberg
CURRENT MEDICAL RESEARCH AND OPINION (2005)
Propranolol for disruptive behaviors in nursing home residents with probable or possible Alzheimer disease - A placebo-controlled study
ER Peskind et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2005)
Noradrenergic activity is associated with response to pindolol in aggressive Alzheimer's disease patients
N Herrmann et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms
TJ Hwang et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2004)
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia
KL Matthews et al.
BIOLOGICAL PSYCHIATRY (2002)
Tyrosine hydroxylase and norepinephrine transporter mRNA expression in the locus coeruleus in Alzheimer's disease
P Szot et al.
MOLECULAR BRAIN RESEARCH (2000)
Share Paper
